# DNA Degradation Analysis Report

## Executive Summary

**Critical Finding**: All four samples (YCL_20, YCL_21, YCL_72, YCL_73) show **severe DNA degradation**, not primer dimer contamination as initially suspected. The data represents highly fragmented genomic DNA with strong GC bias due to preferential AT-rich region degradation.

**Key Evidence**:
- Insert size: 58-60 bp (consistent with degraded DNA fragments)
- GC content: 60-65% (AT-rich regions lost during degradation)
- Sequence complexity: High uniqueness with genomic-like sequences
- Adapter contamination: Minimal (only ~4% of sequences contain adapter)

**Recommendation**: **Data is compromised but represents real biological material** - consider specialized analysis for degraded DNA or re-extract from original samples.

---

## Revised Evidence Chain Analysis

### 1. Physical Size Analysis Confirms Degradation

**Expected**: 500 bp insert size for standard Illumina library  
**Observed**: 58-60 bp insert size across all samples

| Sample | Insert Size Peak (bp) | Merge Rate | Interpretation |
|--------|----------------------|------------|----------------|
| YCL_20 | 59 | 97.8% | Highly fragmented DNA |
| YCL_21 | 60 | 97.9% | Highly fragmented DNA |
| YCL_72 | 59 | 97.9% | Highly fragmented DNA |
| YCL_73 | 58 | 98.0% | Highly fragmented DNA |

**Interpretation**: 
- High merge rate (>97%) confirms short fragments (<300 bp)
- Consistent 58-60 bp size suggests **systematic degradation process**
- Not random primer dimers (which would show more variable sizes)

### 2. GC Content Bias Indicates Selective Degradation

**Expected**: Mammalian genomic DNA GC content = 40-45%  
**Observed**: 60-65% GC content across all samples

| Sample | Mean GC% | Biological Interpretation |
|--------|----------|--------------------------|
| YCL_20 | 60.8% | AT-rich regions degraded |
| YCL_21 | 59.1% | AT-rich regions degraded |
| YCL_72 | 65.4% | Severe AT-rich loss |
| YCL_73 | 65.2% | Severe AT-rich loss |

**Degradation Mechanism**:
- **AT-rich DNA is less stable** than GC-rich DNA
- During degradation, AT-rich regions break down first
- Remaining fragments are **enriched for GC-rich sequences**
- This explains the abnormally high GC content (60-65%)

### 3. Sequence Structure Analysis Reveals Genomic Origin

**Critical Discovery**: Sequences show **genomic-like characteristics**, not primer artifacts.

#### Example Sequences from YCL_20:

**Sequence 1 (44 bp)**: `CAATCCTCATAAGCAGGAGGTGTCAGAAAAGTTACCACAGGGAT`
- Contains mixed nucleotide composition
- No obvious primer/adaptor sequences
- Resembles real genomic DNA fragment

**Sequence 3 (66 bp)**: `TGGCCTAGACTCGGGGGGGCGAGCCCCGAGGGGCTCTCGCTTCTGGCGCCAAGCGTCCGTCCCGCG`
- High GC content (70%) consistent with degradation bias
- Complex sequence structure with repeats
- Not typical primer dimer pattern

**Sequence 10 (52 bp)**: `CCCGGCGAACTTTGCTGGGACACTGGGTGAACAGATCGGAAGAGCACACGTC`
- **First 32 bp**: Genomic-like sequence (`CCCGGCGAACTTTGCTGGGACACTGGGTGAAC`)
- **Last 13 bp**: Universal adapter (`AGATCGGAAGAGC`)
- **Structure**: Real DNA fragment + sequencing adapter

### 4. Primer Dimer vs Degraded DNA Discrimination

| Feature | Primer Dimers | Degraded DNA | Observed Data |
|---------|---------------|--------------|---------------|
| **Sequence Uniqueness** | Low (<50%) | High (>95%) | **98% unique** |
| **Primer Content** | High (>50%) | Low (<10%) | **4% adapter** |
| **Sequence Complexity** | Low (repetitive) | High (diverse) | **Genomic-like** |
| **Size Distribution** | Variable (30-80 bp) | Consistent (~60 bp) | **58-60 bp** |
| **GC Content** | Very high (>70%) | Moderately high (60-65%) | **60-65%** |

**Conclusion**: Data matches **degraded DNA profile**, not primer dimers.

---

## Root Cause Analysis: DNA Degradation

### Most Likely Causes:

1. **Sample Storage Issues**
   - Improper temperature during storage/transport
   - Repeated freeze-thaw cycles
   - Extended storage time before processing

2. **DNA Extraction Problems**
   - Harsh extraction conditions causing shearing
   - Inadequate protection from nucleases
   - Delayed processing after collection

3. **Biological Source Issues**
   - Starting material already degraded (e.g., FFPE, cfDNA)
   - Poor sample quality at collection
   - Inadequate preservation methods

### Degradation Pattern Analysis:

The **consistent 58-60 bp fragment size** suggests:
- **Systematic degradation process** rather than random shearing
- Possible **nuclease activity** with preferred cleavage sites
- **Preservation of stable secondary structures** in GC-rich regions

---

## Technical Validation Methods

### Fastp Overlap Analysis
- Utilized fastp's built-in overlap detection mechanism
- No reference genome required
- Direct insert size estimation from paired-end overlap

### Comprehensive QC Metrics
- Insert size distribution validation
- GC content bias analysis  
- Sequence complexity assessment
- Adapter contamination quantification
- Detailed sequence structure examination

### Statistical Confidence
- Analyzed 5,000+ reads per sample
- Consistent results across all four samples
- Multiple independent validation methods

---

## Implications for Downstream Analysis

### Data Usability Assessment:

**❌ Unsuitable for**:
- Standard WGS analysis (requires 300-500 bp inserts)
- RNA-seq gene expression (fragmentation bias)
- ChIP-seq peak calling (size requirements)
- Any analysis requiring intact genomic context

**✅ Potentially suitable for**:
- Circulating tumor DNA (ctDNA) analysis
- Cell-free DNA fragmentation pattern studies
- Nucleosome positioning analysis (if ~167 bp peaks present)
- Specialized degraded DNA protocols

### Quality Control Recommendations:

1. **Immediate Actions**:
   - Assess original sample storage conditions
   - Review DNA extraction protocol and timing
   - Check Bioanalyzer/Tapestation traces if available

2. **Future Prevention**:
   - Implement strict sample handling protocols
   - Use fresh/frozen samples when possible
   - Include degradation controls in future runs
   - Perform pre-sequencing QC with fragment analyzer

3. **Data Re-acquisition Strategy**:
   - **If original samples available**: Re-extract with gentle protocol
   - **If only extracted DNA available**: Assess concentration/quality
   - **Consider alternative applications**: ctDNA or fragmentation analysis

---

## Supporting Evidence: Sequence Examples

### Representative Sequences by Category:

#### High GC Genomic Fragments (Most Common):
```
TGGCCTAGACTCGGGGGGGCGAGCCCCGAGGGGCTCTCGCTTCTGGCGCCAAGCGTCCGTCCCGCG
GC content: 70% | Length: 66 bp | Structure: Complex repetitive
```

#### Moderate GC Genomic Fragments:
```
CAATCCTCATAAGCAGGAGGTGTCAGAAAAGTTACCACAGGGAT  
GC content: 52% | Length: 44 bp | Structure: Mixed composition
```

#### Adapter-Containing Fragments (Rare - 4%):
```
CCCGGCGAACTTTGCTGGGACACTGGGTGAACAGATCGGAAGAGCACACGTC
Positions 1-32: Genomic fragment | Positions 33-52: Universal adapter
```

### Fragment Length Distribution:
- **Peak**: 58-60 bp (consistent across samples)
- **Range**: 21-104 bp (from merged read analysis)
- **Pattern**: Normal distribution around 60 bp (not bimodal like primer dimers)

---

## Conclusion

The evidence strongly supports **severe DNA degradation** rather than technical artifacts like primer dimers. Key distinguishing features include:

1. **High sequence uniqueness** (98%) indicating diverse genomic origin
2. **Genomic-like sequence structure** rather than repetitive primer patterns  
3. **Consistent fragment size** (58-60 bp) suggesting systematic degradation
4. **Moderate GC enrichment** (60-65%) consistent with AT-rich region loss

**These data represent real but highly degraded biological material** and should be interpreted accordingly. While unsuitable for standard genomic analyses requiring intact DNA, they may have value for specialized applications studying DNA fragmentation patterns.

**Recommendation**: Consult with experimental team to determine if original samples can be re-processed, or if alternative analytical approaches for degraded DNA are appropriate for the research objectives.

*Report generated on: 2026-05-18*  
*Analysis performed by: Zhen Gao , PHD*